10 Questions 40 Answers 0 Followers
Questions related from Dr.Purva Sanganeria Sethi
In what all ways can magnetic nanoparticles with various biocompatible coatings be used for dealing with cardiovascular disorders? What are the newer imaging modalities which can be incorporated...
12 July 2014 4,970 1 View
What is the procedure and what type of instrumentation is required? What can the outcomes be?
02 June 2014 8,133 2 View
What is the minimum threshold value of Iron which should be present for further cytotoxicity analysis? Is it really trustworthy to rely on UV-Vis Spectra of iron oxide nanoparticles?
11 April 2014 4,884 10 View
Are the techniques named as MFM (Magnetic force Microscopy), CD (Circular Dichroism), PPMS (Physical Property measurement system) sufficient to find out this particular information or are there...
29 March 2014 8,776 9 View
Biomedical applications of magnetic iron oxide nanoparticles are widely explored in the field of MRI, Hyperthermia, optics, biosensors and many more. What can be the new approach to apply these...
07 January 2014 6,649 11 View
Some fluorescent dyes for example FITC and rhodamine are stated to be less stable in pH fluctuations. What precautions should be taken to study Actin cytoskeleton and what are the preferred dyes?
06 January 2014 3,597 0 View
What are the basic protocols people are using with ficoll density gradient method, in how many days cells start appearing and taking there fibroblastic morphology, what is the ratio for the...
18 July 2013 3,198 0 View
I have a Roche LDH Cytotoxicity detection kit and want to analyse the percentage of cytotoxicity, what is the role of the several background controls mentioned in the Kit protocol? what are the...
25 June 2013 3,838 1 View
Why are the biocomaptible iron oxide nanoparticles less toxic when compared to the bare nanoparticle ? what is their mode of internalisation? Coated IONPs - internalised (phagocytosis,...
20 June 2013 933 3 View
Iron Oxide nanoparticle behave as contrast agents in MRI
17 June 2013 8,388 2 View